Fig. 5From: Intra- and peritumoral MRI radiomics assisted in predicting radiochemotherapy response in metastatic cervical lymph nodes of nasopharyngeal cancerRepresentative slice of T2WI and CE-T1WI of metastatic cervical lymph nodes (red arrows) before and after radiochemotherapy. (a) A sample in the responder group, Rad-socre of Clinical-radiomic model is 5.739, and the probability to be a responder is 0.996; (b) A sample in the non-responder group, Rad-socre of Clinical-radiomic model is -4.037, and the probability to be a responder is 0.017. The threshold of probability is 0.481. CE-T1WI, contrast-enhanced T1-weighted imaging; T2WI, T2-weighted imagingBack to article page